<DOC>
	<DOC>NCT01238315</DOC>
	<brief_summary>The purpose of this Phase Ib study is to determine if "Human Central Nervous System Stem Cells"(HuCNS-SC) is safe to be transplanted in subjects with infantile and late infantile neuronal ceroid lipofuscinosis. The study will also measure post-transplantation disease progression.</brief_summary>
	<brief_title>Safety and Efficacy Study of HuCNS-SC in Subjects With Neuronal Ceroid Lipofuscinosis</brief_title>
	<detailed_description>Participation in this study will involve screening assessments, surgery to implant HuCNS-SC, medication to suppress immune system and a series of follow-up assessments.</detailed_description>
	<mesh_term>Neuronal Ceroid-Lipofuscinoses</mesh_term>
	<criteria>Age 6 months to 6 years Male or female Clinical diagnosis of Infantile neuronal ceroid lipofuscinosis or late infantile neuronal ceroid lipofuscinosis CLN1 or CLN2 mutation Previously received an organ, tissue or bone marrow transplantation Previously participated in any gene or cell therapy study Infection with hepatitis virus, cytomegalovirus, EpsteinBarr virus, or Human Immunodeficiency Virus (HIV) Current or prior cancer Bleeding disorder Unable to have an MRI scan</criteria>
	<gender>All</gender>
	<minimum_age>6 Months</minimum_age>
	<maximum_age>6 Years</maximum_age>
	<verification_date>January 2015</verification_date>
	<keyword>Batten's disease</keyword>
	<keyword>INCL</keyword>
	<keyword>LINCL</keyword>
	<keyword>Neuronal Ceroid Lipofuscinosis</keyword>
	<keyword>NCL</keyword>
</DOC>